Partner with us to scale Vigicore.
Vigicore Signal Automation and Literature Monitoring are live and growing. We're seeking strategic investment, marketing, and enterprise partnerships to scale the OnePV platform for global pharmacovigilance operations.
A mandatory market, modernising slowly.
Pharmacovigilance is a regulatory requirement for every marketed medicine — a non-discretionary, recurring spend for MAHs and CROs worldwide.
Despite the stakes, signal review and literature surveillance remain fragmented across spreadsheets, repeated data cuts, and disconnected evidence trails.
Vigicore is one governed OnePV platform spanning detection, evidence, literature, and documentation — with room for more PV apps on the same foundation.
A working platform, not a pitch deck.
▹ Two apps, live
Signal Automation and Literature Monitoring are built and running on a shared, multi-tenant platform.
▹ Shared foundation
One identity (SSO + MFA), one MedDRA dictionary, and one audit trail across apps — designed to scale to more tools.
▹ Reviewer-trusted design
Transparent, validated logic and audit-ready traceability — positioned for regulated buyers, not black-box risk.
▹ Built lean
Engineered on a cost-efficient cloud footprint, keeping the path to commercial scale capital-efficient.
Let's find the right fit.
We're open to several kinds of conversation. If any of these describe you, we'd be glad to talk.
Strategic investment
Capital partners who understand regulated life-sciences software and want to back a platform with recurring, compliance-driven demand.
Enterprise & distribution
MAHs, CROs, and PV service providers seeking a modern signal and literature platform — as customers or channel partners.
Marketing & ecosystem
Partners who can accelerate reach across pharmacovigilance, regulatory, and life-sciences technology communities.
Start an investment or partnership conversation.
Share a little about your focus and we'll follow up with a founder conversation and a closer look at the platform, roadmap, and opportunity.
Signal Automation and Literature Monitoring are live and growing. We're seeking strategic investment and enterprise partnerships to scale OnePV.
Read the investment story →